Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 806.85 INR 14.7% Market Closed
Market Cap: 64.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Supriya Lifescience Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supriya Lifescience Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Supriya Lifescience Ltd
NSE:SUPRIYA
Short-Term Investments
₹395.1m
CAGR 3-Years
-7%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Short-Term Investments
₹76.7B
CAGR 3-Years
53%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Short-Term Investments
₹77.9B
CAGR 3-Years
40%
CAGR 5-Years
36%
CAGR 10-Years
18%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Short-Term Investments
₹117.4B
CAGR 3-Years
44%
CAGR 5-Years
21%
CAGR 10-Years
22%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Short-Term Investments
₹3.3B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
6%
M
Mankind Pharma Ltd
NSE:MANKIND
Short-Term Investments
₹30B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Supriya Lifescience Ltd
Glance View

Market Cap
64.9B INR
Industry
Pharmaceuticals

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

SUPRIYA Intrinsic Value
432.04 INR
Overvaluation 46%
Intrinsic Value
Price

See Also

What is Supriya Lifescience Ltd's Short-Term Investments?
Short-Term Investments
395.1m INR

Based on the financial report for Mar 31, 2024, Supriya Lifescience Ltd's Short-Term Investments amounts to 395.1m INR.

What is Supriya Lifescience Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
30%

Over the last year, the Short-Term Investments growth was -54%. The average annual Short-Term Investments growth rates for Supriya Lifescience Ltd have been -7% over the past three years , 30% over the past five years .

Back to Top